| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 04/03/2003 | WO2003027096A1 Substituted 3-pyridyl imidazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027095A1 Substituted 3-pyridyl tetrazoles as steroid c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027094A2 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027090A2 Bicyclic heterocycles as rxr ligands |
| 04/03/2003 | WO2003027085A2 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027083A1 Bicyclo[3,1,0]hexane containing oxazolidinone antibiotic and derivatives thereof |
| 04/03/2003 | WO2003027078A1 Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 04/03/2003 | WO2003027076A2 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
| 04/03/2003 | WO2003027075A2 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 04/03/2003 | WO2003027074A1 Pyrazole derivatives useful in the treatment of hyper-proliferative disorders |
| 04/03/2003 | WO2003026666A1 2-phenylamino-4- (5-pyrazolylamino)-pyrimidine derivatives as kinase inhibitors, in particular, as src kinase inhibitors |
| 04/03/2003 | WO2003026665A1 2-phenylamino-4-(5-pyrazolylamino)-pyrimidine derivatives as kinase inhibitors, in particular, src kinase inhibitors |
| 04/03/2003 | WO2003026664A1 2-phenylamino-4- (5-pyrazolylamino) -pyramidine derivatives as kinase inhibitors, in particular, src kinase inhibitors |
| 04/03/2003 | WO2003026650A1 3-(heteroarylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 04/03/2003 | WO2003026649A1 Methods of increasing endogenous testosterone levels |
| 04/03/2003 | WO2003026589A2 Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides |
| 04/03/2003 | WO2003026587A2 Compounds useful for treating hepatitus c virus |
| 04/03/2003 | WO2002092563A3 Protease inhibitors |
| 04/03/2003 | WO2002086078A3 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents |
| 04/03/2003 | WO2002074738A3 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage) |
| 04/03/2003 | WO2002039954A3 Novel compounds |
| 04/03/2003 | US20030065200 Taxanes having T-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them |
| 04/03/2003 | US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 04/03/2003 | US20030065179 Diabetic therapy |
| 04/03/2003 | US20030065034 Antiinflammatory agents; coupling sulfonyl halide with aromatic amine compound |
| 04/03/2003 | US20030065023 Anticancer agents, viricides, psychological disorders |
| 04/03/2003 | US20030065018 Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 04/03/2003 | US20030065007 Analgesics; psychological disorders; antidepressants |
| 04/03/2003 | US20030065004 Androgen receptor modulators and methods for use thereof |
| 04/03/2003 | US20030064992 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 04/03/2003 | US20030064991 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor |
| 04/03/2003 | US20030064985 Prevent virus reproduction |
| 04/03/2003 | US20030064984 Anticancer agents; side effect reduction |
| 04/03/2003 | US20030064982 Pyrazole compounds useful as protein kinase inhibitors |
| 04/03/2003 | US20030064981 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 04/03/2003 | US20030064977 Viricides |
| 04/03/2003 | US20030064964 Osteoporosis; increase bone density |
| 04/03/2003 | US20030064332 Dye-forming coupler, silver halide photographic light-sensitive material, and azomethine dye compound |
| 04/03/2003 | CA2461467A1 Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 04/03/2003 | CA2461363A1 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors |
| 04/03/2003 | CA2461360A1 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors |
| 04/03/2003 | CA2461128A1 Pyrazole derivatives useful in the treatment of hyper-proliferative disorders |
| 04/03/2003 | CA2460000A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 04/03/2003 | CA2458661A1 Methods of increasing endogenous testosterone levels |
| 04/03/2003 | CA2443410A1 Bicyclo[3,1,0]hexane containing oxazolidinone antibiotic and derivatives thereof |
| 04/02/2003 | WO2002030891A1 Aliphatic nitrogenous five-membered ring compounds |
| 04/02/2003 | EP1298125A1 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 04/02/2003 | EP1297834A1 Inhibitor for enzyme having two divalent metal ions as active centers |
| 04/02/2003 | EP1296990A2 Dihydropyridine compounds for the inhibition of calcium-influx |
| 04/02/2003 | EP1296978A2 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity |
| 04/02/2003 | EP1296976A1 Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them |
| 04/02/2003 | EP1296973A1 Guanidine derivatives of quinazoline and quinoline for use in the treatment of autoimmune diseases |
| 04/02/2003 | EP1296972A1 Arylmethylamine derivatives for use as tryptase inhibitors |
| 04/02/2003 | EP1296959A1 Methods and compositions utilizing quinazolinones |
| 04/02/2003 | EP1296956A1 Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors |
| 04/02/2003 | EP1296950A2 Aminopiperidines for use as glyt-1 inhibitors |
| 04/02/2003 | EP1296949A2 Piperidine amides as modulators of chemokine receptor activity |
| 04/02/2003 | EP1296674A2 Use of substituted indole compounds for increasing nitric oxide synthase activity |
| 04/02/2003 | EP1212312B1 Novel derivatives of flavones, xanthones and coumarins |
| 04/02/2003 | EP1015446B1 (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents |
| 04/02/2003 | EP0991643B1 Novel aminooxyamide tricyclic inhibitors of farnesylprotein transferase |
| 04/02/2003 | EP0951467B1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE |
| 04/02/2003 | EP0894089B9 Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| 04/02/2003 | EP0880518B1 A process of making 3-phenyl-1-methylenedioxyphenyl-indane-2-carboxylic acid derivatives |
| 04/02/2003 | EP0880504B1 Heterocyclo-substituted imidazoles for the treatment of inflammation |
| 04/02/2003 | EP0759908B1 Substituted diazacyclohexandi(thi)ones |
| 04/02/2003 | CN1407990A C-aryl glucoside sgltz inhibitors |
| 04/02/2003 | CN1407982A Serotonergic benzofurans |
| 04/02/2003 | CN1407981A Method for producing 5-(1piperazinyl)-benzofuran-2-carboxamide by transition metal-catalyzed amination |
| 04/02/2003 | CN1407978A Polyhydroxystilbenes and stibene oxides as antisoriatic agents and protein kinase inhibitors |
| 04/02/2003 | CN1407971A Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof |
| 04/02/2003 | CN1407970A Urea compounds having muscarinic receptor antagonist activity |
| 04/02/2003 | CN1104429C 4-(3-heterocycly-1-benzoyl) pyrazoles and their use as herbicides |
| 04/02/2003 | CN1104427C Tricyclic inhibitors of farnesyl protein transferase |
| 04/02/2003 | CN1104424C Triazolyl disulphides |
| 04/02/2003 | CN1104418C Benzoheterocyclic derivatives |
| 04/02/2003 | CN1104409C Aminotetralone derivatives and process for producing same |
| 04/01/2003 | US6541637 Reacting a paroxetine with hydrogen chloride in the presence of isopropyl alcohol and crystallizing the resulting product to form paroxetine hydrochloride anhydrate, drying to reduce amount of isopropyl alcohol to 5% |
| 04/01/2003 | US6541625 Stereoselectively hydrolyzing an anomeric mixture of 2-benzoyloxydioxolanecarboxylate with an enzyme; separating product; replacing carboxylate by reaction with a purine or pyrimidinyl derivative |
| 04/01/2003 | US6541504 Modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation. |
| 04/01/2003 | US6541503 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 04/01/2003 | US6541489 Excellent inhibitory activity of one or more matrix metalloprotease (MMP) enzymes, such as MMP-2, MMP-9, and MMP-13, while exhibiting substantially less inhibition at least of MMP- 1 |
| 04/01/2003 | US6541481 Substituted bicyclic derivatives useful as anticancer agents |
| 04/01/2003 | US6541477 Inhibitors of p38-a kinase |
| 04/01/2003 | US6541476 Piperazine derivatives and their use as anti-inflammatory agents |
| 04/01/2003 | US6541474 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia |
| 04/01/2003 | US6541470 Have a potent antiviral activity against picornaviruses and rotaviruses. |
| 04/01/2003 | US6541242 Using a lipase; anticancer agent |
| 03/27/2003 | WO2003024960A1 Novel use of substituted aminomethyl chromans |
| 03/27/2003 | WO2003024959A1 Polymorphs of a 1-pyrrole derivative, intermediate for the preparation of atorvastatin |
| 03/27/2003 | WO2003024953A1 Propanolamine derivative having 1,4-benzodioxane ring |
| 03/27/2003 | WO2003024950A1 Coumarin derivative |
| 03/27/2003 | WO2003024949A1 Dna-pk inhibitors |
| 03/27/2003 | WO2003024948A1 Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists |
| 03/27/2003 | WO2003024939A2 Triazine compounds polymers comprising triazine structural units, and processes for the preparation of these polymers |
| 03/27/2003 | WO2003024937A1 Benzimidazolylalkoxyaryl alkanoic acid derivatives and their use as antihyperglycemics |
| 03/27/2003 | WO2003024935A2 Substituted pyrazolyl compounds for the treatment of inflammation |
| 03/27/2003 | WO2003024929A1 Substituted piperidines with selective binding to histamine h3-receptor |
| 03/27/2003 | WO2003024928A2 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives |
| 03/27/2003 | WO2003024926A2 Methods and compositions of novel triazine compounds |